Zhejiang Hisoar Pharmaceutical Co., Ltd. (SHE:002099)

China flag China · Delayed Price · Currency is CNY
7.47
-0.06 (-0.80%)
Mar 10, 2026, 2:55 PM CST
64.54%
Market Cap 11.92B
Revenue (ttm) 1.86B
Net Income (ttm) -334.96M
Shares Out 1.58B
EPS (ttm) -0.21
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 33,306,011
Average Volume 90,655,290
Open 7.26
Previous Close 7.53
Day's Range 7.26 - 7.75
52-Week Range 4.26 - 9.09
Beta 0.57
RSI 51.33
Earnings Date Apr 29, 2026

About SHE:002099

Zhejiang Hisoar Pharmaceutical Co., Ltd. engages in the manufacture of pharmaceutical products and dyes in China and internationally. The company offers antibiotics, cardiovascular, hypoglycemic, fine chemicals, formulations, intermediates, and other products. It also provides dyestuff, and intermediates of dyestuff and pigment; and manufactures environmental protection related equipment, medical chemical supplies and appliances, and other chemical intermediates. The company was founded in 1966 and is based in Taizhou, China. [Read more]

Sector Healthcare
Founded 1966
Employees 2,611
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002099
Full Company Profile

Financial Performance

In 2024, SHE:002099's revenue was 1.94 billion, a decrease of -10.75% compared to the previous year's 2.17 billion. Losses were -330.27 million, -21.38% less than in 2023.

Financial Statements

News

There is no news available yet.